Almac Clinical Services, part of the global contract pharmaceutical development and manufacturing organization (CDMO), the Almac Group, has released a case study detailing how the organization’s successful LEAN packaging process supported Pfizer’s urgent mission to dose a child diagnosed with Duchenne Muscular Dystrophy (DMD), with a life enhancing gene therapy.   Pfizer has made a significant effort to extend the life expectancy and improve the quality of life for patients with Duchenne Muscula...